Company Profile

Inflammatix Inc
Profile last edited on: 2/8/2022            CAGE: 7Q4D9            UEI: WK9MLMSHBVL3

Host-response diagnostics: rapid immune system review using multiple mRNA biomarkers and machine learning algorithm
Year Founded
2016
1st Award Year
2017
Latest Award
2021
Program Status
Active
Popularity Index

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

863 Mitten Road Suite 104
Burlingame, CA 94010
   (720) 201-6689
   info@]inflammatix.com
   www.inflammatix.com
Multiple Locations:   
Congressional District:   14
County:   San Mateo

Public Profile

Inflammatix, Inc. is a molecular diagnostics company developing rapid tests designed to 'read' the immune system to improve disease diagnosis. A venture-backed startup and an Alumni of JLab San Francisco, the firm is building novel diagnostics for acute infections and sepsis based on unique immune biomarkers having identified and a capacity to monitor unique combinations of biomarkers present in infectious disease for rapid identification of those in need of emergency care prior to ICU admission. Current methods to diagnose acute infections are focus on ‘finding the bug’ - and approach that is slow and relatively ineffective. Inflammatix has developed a statistically rigorous, extensively validated diagnostic method that affecetvely 'reads'? the immune system. The firm's HostDx™ tests report clinically actionable information on the presence, type (bacterial or viral), and severity of infection in all patients. These results have been extensively validated and published in top-tier medical journals. In addition to the firm's direct-to-Phase II SBIR Award from DARPA, Inflammatix has a $6M BARDA award that could potential be 10-12 times that amount.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
10-14

Awards Distribution by Agency

Key People / Management

  Timothy E Sweeney -- Cofounder, President and CEO

  Amy Boyle -- Chief Operating Officer

  Ljubomir Buturovic -- Vice President of Machine Learning

  Joao Fonseca -- Chief Technology Officer

  Purvesh Khatri -- Co-Founder and Chair Scientific Board

  Oliver Liesenfeld -- Chief Medical Officer

  Jonathan Romanowsky -- Co-Founder and COO